Vanta Bioscience Limited (VANTABIO.BO)
INR 42.57
(0.0%)
INR 42.57
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 609.53 Million INR | 6.63% |
| 2022 | 571.61 Million INR | 27.4% |
| 2021 | 448.66 Million INR | 24.73% |
| 2020 | 359.69 Million INR | 107.09% |
| 2019 | 173.69 Million INR | 31.13% |
| 2018 | 132.46 Million INR | 18.5% |
| 2017 | 111.78 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q4 | 609.53 Million INR | 6.72% |
| 2023 FY | 609.53 Million INR | 6.63% |
| 2023 Q2 | 571.13 Million INR | -0.08% |
| 2022 Q4 | 571.61 Million INR | 21.31% |
| 2022 Q2 | 471.21 Million INR | 5.03% |
| 2022 FY | 571.61 Million INR | 27.4% |
| 2021 FY | 448.66 Million INR | 24.73% |
| 2021 Q2 | 380.87 Million INR | 5.89% |
| 2021 Q4 | 448.66 Million INR | 17.8% |
| 2020 Q2 | 216.48 Million INR | 24.64% |
| 2020 FY | 359.69 Million INR | 107.09% |
| 2020 Q4 | 359.69 Million INR | 66.15% |
| 2019 Q4 | 173.69 Million INR | 32.29% |
| 2019 FY | 173.69 Million INR | 31.13% |
| 2019 Q2 | 131.29 Million INR | -0.88% |
| 2018 FY | 132.46 Million INR | 18.5% |
| 2018 Q4 | 132.46 Million INR | 14.38% |
| 2018 Q2 | 115.81 Million INR | 3.6% |
| 2017 FY | 111.78 Million INR | 0.0% |
| 2017 Q4 | 111.78 Million INR | 38.73% |
| 2017 Q2 | 80.57 Million INR | 7.44% |
| 2016 Q4 | 75 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 55.065% |
| Biocon Limited | 162.76 Billion INR | 99.626% |
| Blue Jet Healthcare Limited | 16.12 Million INR | -3678.897% |
| Concord Biotech Limited | 97.37 Million INR | -525.961% |
| Dishman Carbogen Amcis Limited | 23.12 Billion INR | 97.364% |
| FERMENTA BIOTECH LIMITED | 1.32 Billion INR | 53.918% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 586.5 Million INR | -3.928% |
| Panacea Biotec Limited | 209.9 Million INR | -190.394% |
| SAMSRITA LABS LIMITED | 22.03 Million INR | -2666.594% |
| Servoteach Industries Limited | 5059.00 INR | -12048447.144% |
| SMS Lifesciences India Limited | 1 Billion INR | 39.484% |
| Supriya Lifescience Limited | 54.88 Million INR | -1010.671% |
| Syngene International Limited | 5.55 Billion INR | 89.021% |
| TAKE Solutions Limited | 370.85 Million INR | -64.362% |
| Titan Biotech Limited | 83.02 Million INR | -634.124% |
| Transgene Biotek Limited | 140.01 Million INR | -335.352% |